Clinical Trial Update: 64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating 64Cu-ATSM PET/CT in rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 64Cu-ATSM

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN